The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(1S,2R)-4-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-2-(4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)cyclopentanamine ID: ALA4093096
PubChem CID: 137655616
Max Phase: Preclinical
Molecular Formula: C27H36FN3O2S
Molecular Weight: 485.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)[C@H]1CC(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1
Standard InChI: InChI=1S/C27H36FN3O2S/c1-29(2)26-18-21(23-12-9-20-5-4-6-25(28)27(20)23)17-24(26)19-7-10-22(11-8-19)30-13-15-31(16-14-30)34(3,32)33/h4-8,10-11,21,23-24,26H,9,12-18H2,1-3H3/t21?,23?,24-,26+/m1/s1
Standard InChI Key: ZPYZUHUGHFFSDX-JUNJKAAPSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
2.3376 -9.0626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3417 -9.8876 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.0541 -9.4715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5750 -17.9253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8319 -17.1412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1625 -16.6544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -17.9253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4978 -17.1422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6952 -16.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1439 -17.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4008 -18.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2029 -18.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1597 -15.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8260 -15.3382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5695 -14.5541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7444 -14.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4913 -15.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2582 -13.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5936 -13.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1080 -12.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2867 -12.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9536 -13.3179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4413 -13.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7985 -11.8934 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1336 -11.1384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 -10.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8290 -10.5594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4939 -11.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9799 -11.9843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5237 -9.9779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4414 -16.1854 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.0530 -13.8856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8736 -13.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7158 -13.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
7 4 1 0
4 5 1 0
5 6 1 0
6 8 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
6 13 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
16 18 1 6
24 25 1 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
21 24 1 0
27 2 1 0
2 30 1 0
9 31 1 0
15 32 1 1
32 33 1 0
32 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.67Molecular Weight (Monoisotopic): 485.2512AlogP: 4.06#Rotatable Bonds: 5Polar Surface Area: 43.86Molecular Species: BASEHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.96CX LogP: 4.07CX LogD: 1.55Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.64Np Likeness Score: -0.68
References 1. Curtin ML, Pliushchev MA, Li HQ, Torrent M, Dietrich JD, Jakob CG, Zhu H, Zhao H, Wang Y, Ji Z, Clark RF, Sarris KA, Selvaraju S, Shaw B, Algire MA, He Y, Richardson PL, Sweis RF, Sun C, Chiang GG, Michaelides MR.. (2017) SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding., 27 (7): [PMID:28254486 ] [10.1016/j.bmcl.2017.02.030 ]